Anxiety News and Research

Latest Anxiety News and Research

Chelsea reports positive outcome from DMC review of droxidopa Phase II trial in fibromyalgia

Chelsea Therapeutics International, Ltd. announced the completion and favorable outcome of an independent Data Monitoring Committee (DMC) review of the safety and efficacy data from approximately half the target enrollment in Chelsea's Phase II trial of droxidopa in fibromyalgia.

2 Jul 2010

Does too much texting puts teenagers at risk?

A seemingly harmless method of communication - text messaging on mobile phones could damage teenagers physically and psychologically a new study has revealed.

1 Jul 2010

Studies link anti-cholesterol statin drugs to increased risk of anxiety and depression

Scientists are reporting a possible explanation for the symptoms of anxiety and depression that occur in some patients taking the popular statin family of anti-cholesterol drugs, and reported by some individuals on low-cholesterol diets. These symptoms could result from long-term, low levels of cholesterol in the brain, the report suggests. It appears in ACS' weekly journal Biochemistry.

1 Jul 2010

Calmspace fragrance product to fight claustrophobia

Claustrophobia can be a debilitating condition and while there are a variety of therapies and treatments that attempt to limit its effects, there has never been a truly convenient, discreet and portable option for those seeking immediate and impactful relief in the event of an ensuing claustrophobic attack. Now, Healthy Brands LLC is introducing calmspace™, which delivers a proprietary therapeutic formula of 100% natural fragrance extracts that may help manage the anxiety resulting from claustrophobic reactions.

30 Jun 2010

New hope for patients with drug-resistant depression

New research shows that a unique strain of laboratory mice characterized at Penn State University has behavioral, hormonal, and neurochemical characteristics that are similar to those of human patients with drug-resistant forms of depression.

30 Jun 2010

FDA grants approval for first generic version of Effexor XR antidepressant capsules

On June 28, the U.S. Food and Drug Administration approved the first generic version of Effexor XR capsules (venlafaxine hydrochloride) to treat major depressive disorder.

30 Jun 2010

Oil spill disaster raises concern in the Gulf region

Two months after the Deepwater Horizon oil rig explosion caused the oil spill now globally acknowledged as the worst environmental disaster in our nation's history, the residents of the Gulf region immediately impacted are exhibiting dramatically high levels of anxiety, both among adults and children, about the future health and well-being of the region. Many children – and parents – still recovering from Katrina are now reeling from a second major trauma as a result of the oil catastrophe.

30 Jun 2010

Combination therapy for severe depression

Severe depression is life threatening. So it is worth every effort to get depression under control and make life more manageable. For most people, that means some combination of antidepressant drugs and talk therapy.

29 Jun 2010

New therapy for people suffering from body dysmorphic disorder

A nose job to treat a mental health problem? Teeth whitening to overcome a severe anxiety disorder? These are just two procedures that people with body dysmorphic disorder (BDD) have traditionally turned to in order to deal with body-related concerns.

29 Jun 2010

Researchers use neonatal piglet model to study infant brain development

Events occurring during the development of an infant's brain can leave behind fingerprints. And researchers at the University of Illinois are interested in learning how these fingerprints can predict future behavioral problems such as cognitive deficits, anxiety disorders, depression, and even autism.

29 Jun 2010

Rubella epidemic played a major role in shifting public attitudes toward abortion laws

Ten years before the 1973 Supreme Court decision legalizing abortion - which likely will be a focus of Senate confirmation questions for Supreme Court nominee Elena Kagan next week - German measles probably played the biggest part in starting to shift public attitudes about the criminal abortion laws, University of Illinois historian Leslie J. Reagan says in a new book.

29 Jun 2010

Study finds no link between internet and gambling addictions, but affected individuals have common psychological profiles

A study of university students found no overlap between those reporting excessive Internet use and those with problem gambling.

29 Jun 2010

Forest Laboratories, Gedeon Richter report positive results from radiprodil Phase II study for DPNP pain

Forest Laboratories, Inc. and Gedeon Richter Plc. today announced top-line results from a Phase II placebo and positive comparator-controlled, parallel-arm, double-blind, dose-response clinical trial of the novel, investigational NR2B-selective NMDA (N-methyl D-aspartate) receptor antagonist, radiprodil (RGH-896), for the treatment of neuropathic pain associated with diabetic peripheral neuropathy (DPNP).

29 Jun 2010

CM sufferers experience worse stigma than EM sufferers: Research

Researchers looking for the first time at how migraine sufferers experience the stigmatizing effects of their disease show that chronic migraine sufferers experience worse stigma than episodic migraine sufferers and more than those with other neurological diseases including stroke, epilepsy and MS.

28 Jun 2010

CHMP adopts positive opinion on pending MAA for SYCREST sublingual tablets

Merck announced that the Committee for Medicinal Products for Human Use adopted a positive opinion on the pending Marketing Authorization Application for SYCREST (asenapine) sublingual tablets. The CHMP has recommended that the European Commission grant a marketing authorization for SYCREST for the treatment of moderate to severe manic episodes associated with bipolar I disorder in adults. The CHMP did not support an indication for the treatment of schizophrenia.

25 Jun 2010

Investment report on Somaxon Pharmaceuticals

MicroStockProfit.com announces an investment report featuring Somaxon Pharmaceuticals Inc. The report includes financial, comparative and investment analyses, and industry information you need to know to make an educated investment decision.

25 Jun 2010

Two experimental drugs have potential to restore pumping strength to failing hearts, study finds

We've all experienced the strong heartbeat that accompanies emotions such as fear and rage. But can the body's natural response to these emotions be used to combat heart failure? Results of a study published online today in the journal Circulation Research present a strong case.

25 Jun 2010

Majority of older women seek help for eating disorders

Eating disorders are equal-opportunity offenders – crossing economic and cultural boundaries and leaping the borders of age and gender. For a long time thought to be diseases affecting teens and young women in their 20s, eating disorder treatment centers nationwide are seeing an increase in the population of older women seeking help for eating disorders.

25 Jun 2010

Cognitive behaviour therapy effective for treating anxiety disorders

Brief therapy at the GP's surgery can effectively treat anxiety and depression. Researchers writing in the open access journal BMC Medicine found that cognitive behaviour therapy (CBT) was effective for treating anxiety disorders, while CBT, problem solving therapy (PST) and counseling were all equally effective in treating depression and mixed anxiety and depression.

25 Jun 2010

UCSD School of Medicine receives $5.3M grant to study effect of weight loss in breast cancer survivors

The University of California, San Diego School of Medicine has received a $5.3 million grant from the National Cancer Institute to conduct and lead a first-of-its-kind, four-year clinical trial to show the effects of weight loss and increased physical activity on quality of life and on co-existing medical conditions in overweight breast cancer survivors.

24 Jun 2010

Anxiety News and Research

Latest Anxiety News and Research

Chelsea reports positive outcome from DMC review of droxidopa Phase II trial in fibromyalgia

Does too much texting puts teenagers at risk?

Studies link anti-cholesterol statin drugs to increased risk of anxiety and depression

Calmspace fragrance product to fight claustrophobia

New hope for patients with drug-resistant depression

FDA grants approval for first generic version of Effexor XR antidepressant capsules

Oil spill disaster raises concern in the Gulf region

Combination therapy for severe depression

New therapy for people suffering from body dysmorphic disorder

Researchers use neonatal piglet model to study infant brain development

Rubella epidemic played a major role in shifting public attitudes toward abortion laws

Study finds no link between internet and gambling addictions, but affected individuals have common psychological profiles

Forest Laboratories, Gedeon Richter report positive results from radiprodil Phase II study for DPNP pain

CM sufferers experience worse stigma than EM sufferers: Research

CHMP adopts positive opinion on pending MAA for SYCREST sublingual tablets

Investment report on Somaxon Pharmaceuticals

Two experimental drugs have potential to restore pumping strength to failing hearts, study finds

Majority of older women seek help for eating disorders

Cognitive behaviour therapy effective for treating anxiety disorders

UCSD School of Medicine receives $5.3M grant to study effect of weight loss in breast cancer survivors

Redefining control and consistency in anaerobic microbiome workflows

AI in Healthcare: How generative tools are transforming clinical practice

The future of automation: Machine learning–driven hepatocyte and organoid counting

Anxiety News and Research

Latest Anxiety News and Research

Redefining control and consistency in anaerobic microbiome workflows

AI in Healthcare: How generative tools are transforming clinical practice

The future of automation: Machine learning–driven hepatocyte and organoid counting

Newsletters you may be interested in